RALPH NIVEN

Insider Reports History

Location
Boston, MA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RALPH NIVEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 41,732 $562,965 $13.49 05 Feb 2024 Direct
Aerovate Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 1,609 $28,070 $17.45 05 Feb 2024 Direct

Insider Reports Filed by RALPH NIVEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JBIO Aerovate Therapeutics, Inc. 05 Feb 2024 8 -$70,965 4 CHIEF SCIENTIFIC OFFICER 07 Feb 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 22 Jan 2024 1 $0 4 CHIEF SCIENTIFIC OFFICER 24 Jan 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 05 Jan 2024 9 -$78,832 4 CHIEF SCIENTIFIC OFFICER 08 Jan 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 05 Dec 2023 8 -$65,712 4 CHIEF SCIENTIFIC OFFICER 07 Dec 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 22 Nov 2023 8 -$179,148 4 CHIEF SCIENTIFIC OFFICER 27 Nov 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 05 Jul 2023 9 -$34,360 4 CHIEF SCIENTIFIC OFFICER 07 Jul 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 05 Jun 2023 8 -$32,021 4 CHIEF SCIENTIFIC OFFICER 07 Jun 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 05 May 2023 9 -$42,402 4 CHIEF SCIENTIFIC OFFICER 09 May 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 05 Apr 2023 9 -$36,387 4 CHIEF SCIENTIFIC OFFICER 07 Apr 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 06 Mar 2023 9 -$48,885 4 CHIEF SCIENTIFIC OFFICER 08 Mar 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 06 Feb 2023 9 -$50,057 4 CHIEF SCIENTIFIC OFFICER 08 Feb 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 05 Jan 2023 8 -$54,850 4 CHIEF SCIENTIFIC OFFICER 09 Jan 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 05 Dec 2022 8 -$34,559 4 CHIEF SCIENTIFIC OFFICER 07 Dec 2022, 17:00
JBIO Aerovate Therapeutics, Inc. 07 Nov 2022 11 -$38,639 4 CHIEF SCIENTIFIC OFFICER 09 Nov 2022, 16:00
JBIO Aerovate Therapeutics, Inc. 05 Oct 2022 9 -$30,892 4 CHIEF SCIENTIFIC OFFICER 07 Oct 2022, 17:00
JBIO Aerovate Therapeutics, Inc. 06 Sep 2022 8 -$38,195 4 Chief Scientific Officer 07 Sep 2022, 17:30
JBIO Aerovate Therapeutics, Inc. 18 Aug 2022 8 -$43,102 4 Chief Scientific Officer 19 Aug 2022, 17:00
JBIO Aerovate Therapeutics, Inc. 14 Dec 2021 1 $0 4 Chief Development Officer 16 Dec 2021, 17:00
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Chief Development Officer 29 Jun 2021, 19:42
JBIO Aerovate Therapeutics, Inc. 02 Apr 2021 3 $0 4 Chief Development Officer 01 Jul 2021, 18:35